Join the Oncology Voice Network. Join for Free
Leveraging Creativity to Break into Your First MSL Role
Provide 5 keywords for SEO search separated by commas

Leveraging Creativity to Break into Your First MSL Role


Share This Article


Summary

In this episode, Alec McCarthy shares his insights on breaking into the MSL field with a creative approach. He highlights the 70/30 rule for networking, emphasizing its importance for early-career professionals, and recounts his own journey to securing an MSL position. The discussion covers strategies for effective messaging, particularly when engaging with C-suite executives, and the value of LinkedIn Premium for MSLs. Alec also explores using publishing and scientific literature to enhance job applications, aligning work with personal values, and the significance of persistence and resilience in the job search. The episode concludes with actionable advice for aspiring MSLs.

My guest today is Alec McCarthy, Medical Science Liaison at Merz Asthetics, and we discuss how to leverage creativity to break into your first MSL role.

Alec shares…

πŸ‘‰ What the 70/30 rule is and what the process is about
πŸ‘‰ What is important for aspiring MSLs to get noticed
πŸ‘‰ How to approach companies that you are targeting
πŸ‘‰ What tools and resources to rely on during the search process
πŸ‘‰ Creative tips

Click for Source
Provide 5 keywords for SEO search separated by commas

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
How to Start a Diversity Equity & Inclusion Program in Pharma
Partner Avatar MSL Talk: Tom Caravela, Tara Gonzalez

How to Start a Diversity Equity & Inclusion Program in Pharma

Press Release
Visionaries Behind Oncology Voice Network: Dr. Ramin Farhood & Dr. Kirk Shepard
OVN Avatar OVN Staff

Visionaries Behind Oncology Voice Network: Dr. Ramin Farhood & Dr. Kirk Shepard

Article
Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?
OVN Avatar Omer Ben‐Aharon, Racheli Magnezi, Moshe Leshno, and Daniel A. Goldstein

Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?

Press Release
Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes
OVN Avatar OVN Staff

Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes

Press Release
Introducing OncologyVoiceNetwork.com
OVN Avatar OVN Staff

Introducing OncologyVoiceNetwork.com

Article
Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020
OVN Avatar A. Haslam, M.S. Kim, V. Prasad

Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020

Explore OVN